Guided Therapeutics (GTHP) Liabilities and Shareholders Equity (2010 - 2025)
Guided Therapeutics recorded quarterly Liabilities and Shareholders Equity of $1.3 million in Q4 2025, up 46.62% quarter-over-quarter from $903000.0 in Q3 2025, and down 3.92% year-over-year from $1.4 million in Q4 2024.
Guided Therapeutics' Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity fell 3.92% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $4.1 million (down 23.05% YoY), while the FY2025 annual figure was $1.3 million, down 3.92% from the prior year.
- Liabilities and Shareholders Equity came in at $1.3 million for Q4 2025 at Guided Therapeutics, up from $903000.0 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.9 million in Q3 2022 to a low of $903000.0 in Q3 2025.
- A 5-year average of $1.9 million and a median of $1.7 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity jumped 548.9% in 2021 and plunged 51.51% in 2023, its largest moves.
- Guided Therapeutics' Liabilities and Shareholders Equity stood at $2.0 million in 2021, then surged by 65.0% to $3.4 million in 2022, then plunged by 50.42% to $1.7 million in 2023, then retreated by 17.44% to $1.4 million in 2024, then fell by 3.92% to $1.3 million in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $1.3 million, $903000.0, and $940000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.32 Mn |
| Sep 30, 2025 | 903,000.00 |
| Jun 30, 2025 | 940,000.00 |
| Mar 31, 2025 | 967,000.00 |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 1.88 Mn |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 2.89 Mn |
| Dec 31, 2022 | 3.37 Mn |
| Sep 30, 2022 | 3.87 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 2.19 Mn |
| Dec 31, 2021 | 2.04 Mn |
| Sep 30, 2021 | 1.74 Mn |
| Jun 30, 2021 | 2.07 Mn |
| Mar 31, 2021 | 2.36 Mn |
| Dec 31, 2020 | 1.35 Mn |
| Sep 30, 2020 | 1.30 Mn |
| Jun 30, 2020 | 942,000.00 |
| Mar 31, 2020 | 364,000.00 |
| Dec 31, 2019 | 1.18 Mn |
| Sep 30, 2019 | 339,000.00 |
| Jun 30, 2019 | 260,000.00 |
| Mar 31, 2019 | 404,000.00 |
| Dec 31, 2018 | 236,000.00 |
| Sep 30, 2018 | 491,000.00 |
| Jun 30, 2018 | 418,000.00 |
| Mar 31, 2018 | 527,000.00 |
| Dec 31, 2017 | 406,000.00 |
| Sep 30, 2017 | 905,000.00 |
| Jun 30, 2017 | 1.51 Mn |
| Mar 31, 2017 | 1.49 Mn |
| Dec 31, 2016 | 1.49 Mn |
| Sep 30, 2016 | 2.06 Mn |
| Jun 30, 2016 | 2.31 Mn |
| Mar 31, 2016 | 2.37 Mn |
| Dec 31, 2015 | 2.52 Mn |
| Sep 30, 2015 | 2.77 Mn |
| Jun 30, 2015 | 4.04 Mn |
| Mar 31, 2015 | 2.56 Mn |
| Dec 31, 2014 | 3.03 Mn |
| Sep 30, 2014 | 3.72 Mn |
| Jun 30, 2014 | 3.82 Mn |
| Mar 31, 2014 | 2.60 Mn |
| Dec 31, 2013 | 3.32 Mn |
| Sep 30, 2013 | 2.93 Mn |
| Jun 30, 2013 | 4.40 Mn |
| Mar 31, 2013 | 3.59 Mn |
| Dec 31, 2012 | 3.48 Mn |
| Sep 30, 2012 | 4.77 Mn |
| Jun 30, 2012 | 3.52 Mn |
| Mar 31, 2012 | 3.09 Mn |
| Dec 31, 2011 | 4.31 Mn |
| Jun 30, 2011 | 3.32 Mn |
| Dec 31, 2010 | 3.92 Mn |